Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CAR-T Therapy Complications”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT06383507
What this trial is testing

A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors

Who this might be right for
Metastatic TumorAdvanced Solid TumorRenal Cell Carcinoma+4 more
Zhejiang University 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT06480565
What this trial is testing

A Phase 1/2 Trial of ADI-270 in ccRCC

Who this might be right for
Clear Cell Renal Cell Carcinoma
Adicet Therapeutics 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05982275
What this trial is testing

Trial of an Investigational Drug After Rejecting the Relapse of an Allogeneic Transplant

Who this might be right for
Multiple MyelomaAllogeneic Stem Cell Transplantation
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 25
Very early researchNot Yet RecruitingNCT07423572
What this trial is testing

Clinical Study of Anti-CD19/BCMA Universal Chimeric Antigen Receptor T Cells (UCAR-T) in the Treatment of Refractory Idiopathic Membranous Nephropathy (IMN)

Who this might be right for
Refractory Idiopathic Membranous Nephropathy
The First Affiliated Hospital of Zhejiang Chinese Medical University 18
Testing effectiveness (Phase 2)Looking for participantsNCT06051695
What this trial is testing

Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Who this might be right for
Solid Tumor, AdultColorectal CancerNSCLC+17 more
A2 Biotherapeutics Inc. 474
Testing effectiveness (Phase 2)Looking for participantsNCT07489534
What this trial is testing

Study of PD-1Ab21-BCMA CAR-T Therapy for Consolidation of Multiple Myelomawith Renal Dysfunction

Who this might be right for
Multiple Myeloma
Daihong Liu 25
Early research (Phase 1)Looking for participantsNCT06056102
What this trial is testing

CAR-T Cell Therapy for Desensitization in Kidney Transplantation

Who this might be right for
Kidney TransplantKidney FailureEnd Stage Renal Failure on Dialysis
National Institute of Allergy and Infectious Diseases (NIAID) 20
Early research (Phase 1)Ended earlyNCT03960060
What this trial is testing

CCT301-59 CAR T Therapy in Adult Subjects With Recurrent or Refractory Solid Tumors

Who this might be right for
Solid TumorSoft Tissue SarcomaGastric Cancer+2 more
Shanghai PerHum Therapeutics Co., Ltd. 9
Testing effectiveness (Phase 2)Looking for participantsNCT06839976
What this trial is testing

CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus

Who this might be right for
SLESystemic Lupus Erythematosus (SLE)CAR T Cell+4 more
Children's Hospital of Philadelphia 24
Early research (Phase 1)Looking for participantsNCT07305116
What this trial is testing

CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease

Who this might be right for
Autoimmune DiseasesSystemic Lupus Erthematosus (SLE)Multi-Drug Resistant Nephrotic Syndrome+3 more
The Children's Hospital of Zhejiang University School of Medicine 15
Early research (Phase 1)Looking for participantsNCT06553898
What this trial is testing

Study of Therapeutic Efficacy of CAR-T Cell Therapy in Patients With MDR-SRNS

Who this might be right for
Multi-Drug Resistant Nephrotic SyndromeCAR-T Cell Therapy
The Children's Hospital of Zhejiang University School of Medicine 18
Not applicableUnknownNCT05752877
What this trial is testing

Safety and Efficacy of Targeted IL-13 Rα2 or B7-H3 UCAR-T for Advanced Glioma

Who this might be right for
Advanced GliomaComplication of Chimeric Antigen Receptor (CAR-T) Cell Therapy
Second Affiliated Hospital of Soochow University 12
Not applicableLooking for participantsNCT04892433
What this trial is testing

Tissue Study in Patients Undergoing CAR-T Cell Therapy (CAR_21_01)

Who this might be right for
CAR-T Therapy Complications
IRCCS Azienda Ospedaliero-Universitaria di Bologna 150
Early research (Phase 1)Looking for participantsNCT06308978
What this trial is testing

FT819 in B-cell Mediated Autoimmune Disease

Who this might be right for
Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV)Idiopathic Inflammatory Myositis (IIM)Systemic Sclerosis (SSc)+2 more
Fate Therapeutics 244
Testing effectiveness (Phase 2)Ended earlyNCT05938725
What this trial is testing

KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis

Who this might be right for
Lupus NephritisLupus Nephritis - World Health Organization (WHO) Class IIILupus Nephritis - WHO Class IV
Kyverna Therapeutics 6
Early research (Phase 1)Looking for participantsNCT07216105
What this trial is testing

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

Who this might be right for
Non-Small Cell Lung CancerColorectal CancerBreast Cancer+3 more
Fate Therapeutics 119
Very early researchNot Yet RecruitingNCT06681337
What this trial is testing

Universal CAR-T Cell Therapy for Refractory Lupus Nephritis

Who this might be right for
Lupus Nephritis
Bioray Laboratories 10
Not applicableLooking for participantsNCT06902844
What this trial is testing

Equecabtagene Autoleucel Injection (Eque-cel) for Relapsed/Refractory Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)
Tongji Hospital 6
Testing effectiveness (Phase 2)Looking for participantsNCT06897930
What this trial is testing

Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

Who this might be right for
Lupus Erythematosus, Systemic
AstraZeneca 150
Not applicableUnknownNCT05190653
What this trial is testing

Early Integration of Palliative and Supportive Care in Cellular Therapy

Who this might be right for
LeukemiaLymphomaMultiple Myeloma+3 more
Alberta Health Services, Calgary 152
Next Page